Pfizer India Shares Rise 1.5% After Strong Q2 FY26 Earnings

Mumbai, November 13, 2025: The share price of Pfizer Limited traded higher on Thursday, extending its upward momentum during the mid-session at 2:00 PM IST. The stock was quoted at ₹5,096, up 1.56% from its previous close of ₹5,015.50. The rally came on the back of the company’s strong Q2 FY26 financial results, which boosted investor confidence in the counter. Earlier in the session, the stock opened at ₹5,164, hit an intraday high of ₹5,339, and touched a low of ₹5,075.50.

As of November 13, 2025, total traded volume stood at 107,000 shares, with a turnover of around ₹55.93 crore. The VWAP (Volume Weighted Average Price) was recorded at ₹5,227.37, reflecting sustained buying interest in the stock.

Q2 FY26 Earnings Lift Sentiment

Pfizer India recently reported a strong set of quarterly results. The company posted a net profit of ₹189.02 crore for Q2 FY26, marking a 19.4% year-on-year (YoY) increase. Revenue from operations stood at ₹642.34 crore, up 9.1% YoY, while total income rose to ₹684.19 crore, reflecting steady business growth and operational efficiency.

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations